Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
CTTH Insider Trading and Fund Holdings (CTT PHARMACEUTICAL HOLDINGS, INC.) · https://wallstpal.com/stock/ctth/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1035422

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH): Insider Trades and Fund Holdings

In the past 12 months, CTT PHARMACEUTICAL HOLDINGS, INC. insiders reported 15 open-market purchases worth $5K and no sales.

15Insider buys, 12 months
$5KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 26, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $335
  2. Oct 15, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $114
  3. Oct 6, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $204
  4. Sep 28, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $187 (5 days after: signed a material agreement)
  5. Sep 23, 2026NewsCompany reported: Signed a material agreement
  6. Sep 22, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $455
  7. Sep 16, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $523
  8. Sep 10, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $175
  9. Sep 4, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $479
  10. Sep 2, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $147
  11. Aug 31, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $172
  12. Aug 24, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $116
  13. Aug 20, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $518
  14. Aug 19, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $590
  15. Aug 14, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $112
  16. Aug 7, 2026Insider buyCEO Ctt Pharmaceutical Holdings, Inc. bought $501

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 26, 2026.

Recent CTTH insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHoldingFiling
Oct 26Oct 26Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY5,8800.057$33519+0.1%Form 4 ↗
Oct 19Oct 15Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY2,0000.057$11417+0.0%Form 4 ↗
Oct 6Oct 6Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY3,7000.0551$20417+0.0%Form 4 ↗
Sep 28Sep 28Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY3,4000.055$18717+0.0%Form 4 ↗
Sep 22Sep 22Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY10,1000.045$45519+1.0%Form 4 ↗
Sep 16Sep 16Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY10,9000.048$52319+0.1%Form 4 ↗
Sep 10Sep 10Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY3,5000.05$17517+0.0%Form 4 ↗
Sep 4Sep 4Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY9,8000.0489$47919+0.1%Form 4 ↗
Sep 2Sep 2Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY3,0000.049$14717+0.0%Form 4 ↗
Aug 31Aug 31Ctt Pharmaceutical Holdings, Inc.CEOCEO▲ BUY3,5000.0491$17217+0.0%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 15 CTTH insider trades →

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Ctt Pharmaceutical Holdings, Inc.CEO15$5K0$0Oct 26, 2026
Strongest purchase, 12 months

19 Ctt Pharmaceutical Holdings, Inc. (CEO), 2026-10-26. What the score means

Filing quality

A All 15 insider trades reported on time. How it is graded

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →